Overall uptake of those eligible for cancer screening programmes were bowel cancer (stool sample) 89%, breast cancer (mammography) 94%, cervical cancer (smear) 87% and prostate cancer (PSA measurement) 43%. This evidence concerns the gene KLK3 and cervical cancer.